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A B S T R A C T
Introduction: Latest advances made in joint replacement implants allows reconstruction of entire limbs. These
special prostheses or megaprostheses were originally designed for the treatment of severe oncological bone loss.
Nowadays, however, the indications and applications of these devices are expanding to other orthopaedic and
trauma clinical conditions. Since 2008 we have implanted 152 megaprostheses in non-oncological conditions: 87
were implanted for post-traumatic failures aseptic/septic (represented by complex non-unions and critical size
bone defects); 26 total femur, 52 distal femur and 9 proximal tibia. In this group of patients bone and soft tissues
conditions are completely different compared to patients with oncological back ground. The presence of infection
and previous surgeries can lead to adhesion, scar interference, muscular and tendon impairment and skin
problems that lead to reduced function and severe joint stiffness. The purpose of this study is to evaluate the
results of treatment of reconstruction of patellar tendon during implantation of proximal tibia megaprosthesis for
the treatment of septic post traumatic critical bone defects.
Patients and methods: In this retrospective study, we evaluated 9 patients treated with proximal tibia mega-
prosthesis who underwent patellar tendon reconstruction. All patients presented a complete patellar tendon
disruption at the time of prosthesis implantation. Procedures of reconstruction included a tendon-plasty of
quadriceps and/or patellar tendons, a pie crusting of quadriceps fascia, a reinforcement of the apparatus with
synthetic tendon graft substitutes (LARS) and a medial gastrocnemius muscular flap to reconstruct the extensor
mechanism and obtain skin coveragewhen needed. The average follow up was 18 months (9–36). For each of the
cases, we analysed the complications occurred regarding septic recurrence, patellar fracture, quadriceps and
patellar tendon rupture and number of reinterventions. The clinical outcome was assessed by the WOMAC Score.
Results: In all cases there was no infection recurrence or skin related problems. None of the patients require
prosthesis revision due to loosening or device failure. No patellar fracture or quadriceps tendon failure was
recorded.
One patient presented a rupture of the reconstructed patellar tendon due to a trauma incident 18months after the
implantation and he required revision surgery. From a clinical point of view the average WOMAC score was 62.4
at 1 month rising to 72.6 at 3 months, 78.2 at 6 months, 76.4 at 1 year and 74.8 at 18 months.
Conclusion: When proximal tibia megaprosthesis is implanted and there are soft tissue and patellar tendon
deficiency, soft tissue reconstruction can be achieved by appropriate lengthening of the tendon and a
gastrocnemius flap reinforced by LARS. Such an approach allows restoration of the extensor mechanism and
coverage of the prosthesis in an area where skin problems are frequently very common.
© 2016 Elsevier Ltd. All rights reserved.





Critical bone defect of traumatic or prosthetic origin continue to be
a complex problem for the orthopaedic surgeon. Patients not
infrequently have undergone a numberof previous procedures limiting
the options of reconstruction or may possess a number of
* Corresponding author at: Massimiliano Colombo, Reparative Orthopaedic Surgery
Department – ASST Pini-CTO, University of Milan, Piazza Cardinal Ferrari 1, 20122 Milan,
Italy. Tel.: +390258296904; Fax. +390258296905; Mobile: +393381687665.
E-mail address: maz.colombo@hotmail.it (Massimiliano Colombo).
Injury, Int. J. Care Injured 47S6 (2016) S77–S82
Contents lists available at ScienceDirect
Injury
j ou rna l homepage: www. e lsev ier .com/ locate / In ju ry
0020-1383 / © 2016 Elsevier Ltd. All rights reserved.
comorbidities which impair the healing potential of the affected
extremity. The aetiology of critical bone defects include acute
traumatic loss, extended bone resections performed to treat non-
union or underlying septic complications.
Although bone reconstruction techniques have been developed and
refined over the years, their applications can still lead to long-term
treatment and complications may occur leading to serious long-term
impact on both the qualityof life of the patient and on thewelfare costs.
There are various reconstructive strategies to treat bone defects
such as autograft and allogeneic bone grafting, bone transport,
biological based therapies in the form of monotherapy [1] or
polytherapy [2,3], the use of standard prosthesis and/or
megaprosthesis.
Lately, a classification system NUSS (Non Union Scoring System)
was introduced allowing the evaluation of the risk factors and
comorbidities of the patient, bone and other tissues, which can be
used to obtain a prognosis and to provide guidance on surgical
treatment [4,5]. Patients with a score higher than 75 points present
very compromised general and local conditions and further recon-
structive treatment is not recommended. The recommendations
for this group of patients include primary amputation, arthrodesis or
the implantation of a prosthesis. In patients who do not wish to
consider primary amputation as a solution of their problem, our
approach to provide a reasonable functional solution has been the
replacement of all or part of the affected extremity with mega-
prosthesis. Our philosophy of substitution treatment can quickly
restore function rather than chasing again unsuccessful attempts to
reconstruction [6,7].
In such cases, bone and soft tissues conditions are completely
different from the routine oncological patient group. The quality of the
knee extensor mechanism is very often in a critical condition
particularly in post-traumatic septic patients who have undergone
multiple surgeries. Tissue adhesion, scar interference, muscular and
tendon impairment, soft tissue retractions, osteoporosis and skin
problems lead to a reduced function of the knee, severe joint stiffness
and also create adverse condition during the reconstructive step.
A specific complication that can lead to very poor results involves
anterior tibial apophysis avulsion and partial tear or complete
disruption of the patellar tendon. In such case, limitations exist
intraoperative on how to restore the tendon loss and post-operatively
how to manage the rehabilitation program of the patient. In addition,
in cases where the entire proximal part of tibia is removed,
reconstruction of the extensor apparatus must be reinserted directly
into the prosthesis and adequate soft tissuemust be present to cover to
prosthetic component. In this study, we present our results of
reconstruction of patellar tendon during implantation of proximal
tibia megaprosthesis for the treatment of septic post traumatic critical
bone defects.
Patients and methods
Between January 2008 and January 2016 we treated 152 non
oncological patients with mega-prosthesis for large bone resections.
The implants performed were: 54 proximal femurs, 52 distal femurs, 9
proximal tibias, 7 distal tibias, 26 total femurs, 4 arthrodesis for large
resection of the knee. The implant used in all cases was the prosthesis
Megasystem-C (Waldemar LINK, Germany). In this retrospective
analysis we evaluated 9 patients treated with proximal tibia mega-
prosthesis who underwent patellar tendon reconstruction. All the
patients presented a septic condition and were treated in two surgical
steps (1st step: device removal + resection of septic bone and non-
union + implantation of antibiotic spacer; 2nd step: after an average
period of 3 months: removal of the antibiotic spacer and implantation
of definitive mega-prosthesis). The average follow up time was 18
months (9–36) since the second procedure. All patients presented a
complete patellar tendon disruption at the second stage.
Techniques of reconstruction
• Tendon-plasty of the quadriceps and/or patellar tendons to stretch
the tendon fibres and enable functional reconstruction (9/9
patients) (Figure 1).
• Pie crusting of quadriceps fascia to lengthen it and enable
functional reconstruction and future mobilization, thus reducing
the strain on the new apparatus and limiting new rupture (7/9
patients) (Figure 2).
• Anchoring the apparatus reinforced by synthetic tendon graft
substitutes (LARS) directly to the prosthetic element using an
appropriate plate built for this purpose (9/9 patients) (Figure 3).
• Medial gastrocnemius muscular flap to reconstruct the extensor
mechanism (9/9 patients) and obtain skin coverage if needed (5/9
patients) (Figure 4).
• Reinforcement of the patella through peripheral cerclagewith non-
absorbable metal core wire in patients with severe osteoporosis
and at high risk of fracture (3/9 patients).
All reconstructions were performed by a single operator and by the
same team during this period. Patient follow-up was performed with
Fig. 1. Tendon-plasty for lengthening the quadriceps tendon.
Fig. 2. Pie crusting of quadriceps fascia.
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clinical and radiographic evaluations at 45 days 3-6-12-18-24-36
months.
The mean age of patients was 68 years (43–89); 6 patients were
male and 3 were female. The average NUSS score was 82 (76–92).
Implants used were cemented with an antibiotic cement, the choice of
the antibiotic cement was by the strain and sensitivity of the bacteria
isolated during the first surgery. All patients were mobilized on the
second postoperative day and prescribed an articulated brace locked in
extension between 0 and 30° of flexion for not less than 30 days.
Subsequently, physiotherapy programwas initiated focusing onmuscle
strengthening exercises and on improvement of active and passive
range of motion of the knee. For each case, we analysed complications
occurred regarding septic recurrence, patellar fracture, quadriceps and
patellar tendon rupture, number of reinterventions. Clinical results
were evaluated using the WOMAC Score.
Results
In all cases we had not infection recurrence or skin related
problems. None of the patients require prosthesis revision due to
loosening or device failure. No patellar fracture or quadriceps ten-
don failure was recorded. One patient presented a rupture of the
reconstructed patellar tendon due to a trauma fall 18 months after the
implantation procedure and necessitated revision surgery (Figure 5).
The average WOMAC score was 62.4 at 1 month rising to 72.6 at 3
months, 78.2 at 6 months, 76.4 at 1 year, and 74.8 at 18 months.
Discussion
The treatment of non union with gaps and bone defects remains a
clinical challenge [8–13]. When the location of the defect is in close
proximity to the articular surface and particularly in the background of
infection treatment options remain limited with the use of a
megaprosthesis being one of them to restore function. This case
scenario is commonly found in the proximal tibia where in addition to
the affected bone that need to be replaced, ligament and soft tissue
envelope reconstruction is essential for reducing the risk of failure and
functional impairment.
Extensor mechanism disruption is a frequent source of post-
operative morbidity. It is a quite rare entity (0.7–2.7%), but most
often presents in the setting of a megaprosthesis implantation due to
multiple previous surgeries and infection [8]. Discontinuity in any
of its components can lead to an extensor mechanism failure and
render an otherwise perfectly good prosthesis useless. Hence there is a
need to reconstruct a functional apparatus when it is completely
absent.
Fig. 3. Reinforcement of the patellar tendon using synthetic tendon graft substitutes
(LARS) and tendon anchoring at the prosthetic component using dedicated plate.
Fig. 4. Medial gastrocnemius muscular flap to reconstruct the extensor mechanism and obtain soft tissue coverage.
G. M. Calori et al. / Injury, Int. J. Care Injured 47S6 (2016) S77–S82 S79
The ideal surgical management of extensor mechanism disruption
remains controversial. The treatment options for the repair include
direct primary repair, or reconstruction with a synthetic ligament,
autograft, or allograft tissue [14,15]. Various treatment options are
available for managing these challenging issues, and recent advances
in alternative techniques have yielded promising results.
The degree of mechanical compromise should always drive the
surgeon towards a particular surgical treatment. The latter is
determined by the amount of disruption (patellar tendon, patella, or
quadriceps tendon), degree of functional impairment (partial versus
full tear), acute versus chronic nature of the disruption, availability of
healthy tissue for either direct primary repair or augmentation, and the
compliance of the patient [16]. Direct primary repair is a viable option
in some cases and most often is a repair that involves patellar tendon
ruptures. Quadriceps tendon tears should be carefully evaluated before
planning a direct repair. A large review that studied exclusively
quadriceps tendon ruptures showed a fairly high incidence of poor
results after open surgical repair. But when facing a complete and
chronic rupture a quadriceps turndown, allograft reconstruction or
synthetic graft is probably the best option [17–24].
Acute avulsions of the patellar tendon from bone can be treated
with sutures in the soft tissue and either drill holes in bone, staples or
screws or suture anchors in the bone. In the mid-substance tear,
usually end to end repair is the choice of treatment. Chronic patellar
tendon tears, however, tend to be complicated by retraction or
shortening of the extensor mechanism. This can make it difficult to
get a tension free repair, which is essential to achieve adequate healing
of the affected tissue. Autograft can be used as an augment to enhance
the tensile strength of the repair or as tendon transfers to improve this
substantial loss of function. In the first setting usually semitendinosus
autograft is used; this technique requires a tendon harvest maintaining
its distal attachment. The tendon is then passed through a transverse
hole created in the inferior patella and then reattached distally into
remaining soft tissue at the tendon origin. The gracilis tendon can also
be harvested and attached to the semi-tendinosis for additional length
if needed [21]. Allograft reconstruction is an alternative option that
can restore active extension of the knee [22–24]. The main advantage
of this technique is to avoid autologous harvesting, reducing the
morbidity of the surgical procedure. Moreover, some studies show that
biological integration is similar to autografts [25].
The options for allograft reconstruction include an en bloc extensor
mechanism allograft (EMA, comprising quadriceps tendon, patella,
patellar tendon, and tibial tubercle allograft) or an Achilles tendon
bone block allograft (ATA) [26–29]. Although the original series of EMA
showed good results [21,22], some other series have shown that the
rate of failure appears to be a critical issue [23,30], especially following
re-revisions [31]. Satisfactory experiences have been reported with the
ATA by some authors [8,32,33], with results comparable to EMA in
terms of success [32]. The most comprehensive report on this
technique is by Diaz-Ledezma et al. [34], where his study demon-
strated a modest 58.6% success rate in 29 knees at a mean follow-up of
3.5 years. Although a clear advantage of an Achilles tendon allograft in
the case of an isolated patellar tendon disruption is preservation of the
native patella, our experience is that proximal fixation of the graft is
more difficult. Allograft technique, however, is not without potential
complications; the risk of recurrent extensor mechanism disruption is
evaluated between 5% and 100% [8,28,30,32]. Recurrence is mostly
seen after unsuccessful ATA fixation or more frequently proximal
fixation in the quadriceps tendon. Another causative factor supported
by some authors is gradual elongation of the soft tissues to explain this
complication [30]. Secondary disruption can be prevented by a stable
primary fixation as well as by immobilization in extension of at least 6
to 8 weeks [23]. A postoperative extensor lag seen during active
extension is a major prognostic feature, the mean is 15° [32] but has
been found to reach 59° [30]. An extensor lag can be partially
prevented by tensioning the graft and by keeping the limb in full
extensionwhile securing the quadriceps [24]. Concernswith the use of
allograft include tissue availability, cost, immune reaction, and disease
transmission [35].
Synthetic grafts are another option for EM reconstruction. One
major advantage of this syntheticmaterial overallograft is the apparent
maintenance of tensile strength and avoidance of graft elongation
with time.
The use of a synthetic graft for an extensor mechanism reconstruc-
tion includes LARS [36], Leeds-Keio ligament [37], Trevia tube [38] and
the mesh [39,40]. Dominkus et al. reported the use of LARS for the
reconstruction after tumor resection, and the mean degree of the
extension lag among the patients who had a resection of the proximal
tibiawas 25° (range, 0–90) [29]. Browne andHannsen [40] reported the
use of the mesh for extensor reconstruction in 13 conventional TKAs
Fig. 5. On the left: rupture of the reconstructed apparatus after new trauma; on the right: new reconstruction using synthetic tendon graft substitutes in strings (LARS) and
mesh (ARTELON).
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and the mean extension lag (except cases of graft failure) measured
2.8°.Wovenmonofilamentmesh canprovide a framework for ingrowth
of host tissue, with resultant orderly collagen formation that resembles
normal ligament tissue [41]. The heavy-weight mesh also provides a
good substrate for immediate suture fixation and in augmenting the
often friable and compromised host tissue. Reconstruction with
synthetic mesh eliminates the potential for disease transmission that
is potentially associated with allograft implantation. Although the
monofilament mesh is a foreign body, it has been shown to be unlikely
to act as a nidus for microbial growth and may be beneficial as
compared with the use of natural material such as collagen, which can
serve as a potential binding site for bacteria [42–44]. Several studies
showed no decrease in tensile strength of themesh and biomechanical
superiority over grafts [40,45–49].
A salvage technique that can be used for both reconstruction of the
extensor mechanism and the skin coverage is a medial gastrocnemius
muscle flap. This option has been described for combined tissue loss
during revision knee arthroplasty or tumour surgery [48–52]. The
medial gastrocnemius flap is a standard technique for soft tissue
coverage and is reportedly safe and reliable with low donor site
morbidity. Malawer et al. was the first that described medial
gastrocnemius reconstruction of the extensor mechanism in four
tumour patients with knee endoprosthesis [50]. Similarly, several
authors [15,48,49,51] have reported very good results using this flap
after patellar or quadriceps tendon loss during complicated knee
arthroplasty. However, in some cases gastrocnemius flaps may be
insufficient to close defects of the lower portion of the capsule of the
knee and are never adequate for defects involving the quadriceps
tendon and rectus femoris muscle [51,53]. In this case scenario, the
latissimus dorsi free flap [25], vastus medialis and lateralis flap,
reversed gracilis pedicle flap [37], distally based vastus lateralis flap [8],
rectus abdominus free flap [13], perforator flaps [24,31], and
neurofasciocutaneous flaps [38] all have the potential to close large
anterior defects but are technically demanding and require a plastic
surgeon assistance. So local muscle and tendon transfer is a common
practice to overcome diminished knee function.
This study is not without limitations, the main one being its
retrospective nature and the small number of cases. However, extensor
mechanism disruption is a rare and not predictable complication; a
retrospective approach seems unavoidable in studying this difficult
problem.
In conclusion, we believe, that the use of allograft is not the safest
option in patients affected by post-traumatic and periprosthetic bone
defects especially in a previous septic environment. Infections are the
main cause of failure after prosthetic revision as revealed by recent
studies with a risk thatmay be 10-fold higher than primary procedures
[54,55]. We recommend the use of synthetic materials to reinforce the
apparatus, when a direct repair is not possible. When proximal tibia
megaprosthesis is implanted we suggest to prepare the soft tissues by
an appropriate lengthening and to perform a gastrocnemius flap
reinforced by synthetic tendon graft substitutes (LARS) in order to
restore the extensor apparatus and to cover the prosthesis in an area
where skin problems are always very common.
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